Veracyte | VCYT - 现金及等价物

金融业

USD

USD 1.41B

现金及等价物

USD 362.58M

USD 39.29M

USD 488.38M

USD 59.94M

USD 40.45M

USD 24.63M

USD 42.31M

824

EPS每股收益

USD 0.53

股本和储备

USD 1.26B

USD 101.97M

债务利息支出

USD 2K

USD 3.48M

USD 0

USD 2.5B

USD 41.15M

USD 116.01M

USD 24.63M

普通股股本

USD 79.05M

45.3

USD 40.63M

USD 140.6M

销售和管理费用

USD 43.31M

USD 20.55M

贸易债权人

USD 4.59M

应收帐款人

USD 44.66M

	现金及等价物	更改		日
Agenus	USD 3.46M		6.08M	2025-09
Agilent	USD 1.76B		31M	2025-12
Anika Therapeutics	USD 57.48M		509K	2025-12
Arrowhead Research	USD 201.64M		112.94M	2025-12
Bruker	USD 293.1M		201.1M	2025-09
Exact Sciences	USD 956M		166.96M	2025-12
Heron Therapeutics	USD 43.07M		26.55M	2025-09
Illumina	USD 1.42B		368M	2025-12
Intrexon	USD 9.34M		1.77M	2024-06
Karyopharm Therapeutics	USD 37.67M		1.05M	2025-09
Laboratory Of America	USD 532.3M		65.8M	2025-12
Ligand Pharmaceuticals	USD 174.93M		489.59M	2025-12
Myriad Genetics	USD 149.6M		4.2M	2025-12
Rigel Pharmaceuticals	USD 48.53M		4.87M	2025-09
Roche Holding	CHF 7.55B		579M	2025-06
Sangamo BioSciences	USD 38.34M		13.16M	2025-06
Siemens	EUR 14.5B		146M	2025-09
Sonic Healthcare	AUD 645M		25.39M	2024-06
Thermo Fisher Scientific	USD 9.85B		7.87B	2025-12
Veracyte	USD 362.58M		47M	2025-12
Waters	USD 587.83M		128.71M	2025-12